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INTRODUCTION
In many of the world's developed countries, the number of
overweight and obese young people is increasing (Ogden et
al., 2006). Observations show that 1.1 billion adults are
overweight (312 million of them are obese) and 155 million
children are overweight or obese (Hossain et al., 2007). Ap-
proximately 18 million of the people in the world suffering
from diabetes and hypertension die each year from cardio-
vascular diseases (Hossain et al., 2007). Prospective studies
(19) have proven that overweight, obesity and increased
mortality are strongly linked. All-cause mortality is lower
when body mass index (BMI) is 20.0–24.9 (De Gonzalez et
al., 2010).
The term ‘metabolic syndrome’ was first used in 1988
(Reaven, 1988). It combines cardiovascular risk factors and
diabetes. Since then, the concept of metabolic syndrome has
been updated, its etiological factors are being investigated,
and the possible pathogenic mechanisms and guidelines are
being developed. The main risk factor for metabolic syn-
drome is overweight and obesity (particularly abdominal),
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Many studies have shown that systolic and diastolic arterial blood pressure changes due to
higher weight in both school-age children and in adolescents. Abnormalities of thyroid function
might be no less important factor in relation to metabolic syndrome. The objective of the study
was to determine the relationship of arterial blood pressure, glucose, adiponectin and thyroid
function parameters to major risk factors of metabolic syndrome. The risk factors tested were
body mass index (BMI) and waist circumference in female students aged 18 to 25 years. We
studied 105 RSU Red Cross college students aged 18 to 25 years. We calculated their BMI, lung
vital capacity (ml), thyroid changes by ultrasound (USG) (27 students) and ECG (79 students). In
addition, we measured their waist and chest circumferences, and systolic and diastolic blood
pressure in both arms. We determined concentration of glucose, adiponectin, thyroid stimulating
hormone (TSH) and free thyroxine (FT4) in blood. Statistical analyses were performed using the
SPSS 15.01 package software. There was a statistically significant positive correlation between
the arterial blood pressure, BMI and increase of the waist circumference in students (average age
20.7 years). The average arterial blood pressure in students was normal. The age at the onset of
menarche had a significant positive effect on diastolic arterial blood pressure (P = 0.009–0,017).
An increase in blood glucose concentration was closely associated with BMI (P = 0.03) and waist
circumference (P = 0.045). However, adiponectin concentration was correlated with systolic (P =
0.007–0.048) and diastolic (P = 0.002–0.003) blood pressure. Significant ECG changes were
found in 10% of the subjects, indicating cardiovascular changes in these young women. The
higher the FT4 and TSH concentrations, the more frequently were observed changes in the ECG
ST-segment (P = 0.01–0,008). A significant relationship between diastolic blood pressure and the
age at onset of menarche (P = 0.009–0.017) was found. Increased arterial blood pressure was
associated with an increase in BMI, waist circumference and adiponectin concentration, while an
increase in blood glucose concentration was associated with increased BMI and waist circumfer-
ence, but not with the adiponectin level. Changes in ECG and increased diastolic arterial blood
pressure in relation to menarche indicate a possible role of the endocrine system and genetic fac-
tors in regulation of the main parameters of metabolic syndrome.
Key words: metabolic syndrome, systolic arterial blood pressure, diastolic arterial blood pressure,
thyroid gland, thyroid stimulating hormone, free thyroxin.
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which are the main criteria of metabolic syndrome in the
classification developed by the International Diabetes Fed-
eration in 2005 (Alberti et al., 2005).
Metabolic syndrome is diagnosed more frequently in obese
adults (50% of cases) (Weiss et al., 2004). The place where
the fat or “ectopic” fat accumulates is important. The patho-
physiological condition called “adiposopathy” (Bays, 2009)
is characterised by adipocyte hypertrophy, increased size of
adipose tissue and accumulation of ectopic fat (visceral fat).
This contributes to the development of cardiovascular dis-
eases and type 2 diabetes mellitus, as well as to a rise in
systolic and diastolic arterial blood pressure. Hypertension
is the main risk factor for cardiovascular disease (Ferrannini
et al., 2008; Wilson et al., 2008).
The pathological mechanism of metabolic syndrome is still
not clear. Metabolic syndrome combines the main risk fac-
tors for cardiovascular diseases and type 2 diabetes mellitus
— central adiposity, insulin resistance, glucose intolerance,
dyslipidemia and hypertension. Fat is considered an endo-
crine organ, which promotes hormonal and bioactive sub-
stance function. One of these bioactive substances is an
adipokine, whose role in the pathogenesis of metabolic syn-
drome is very high (Kadowaki et al., 2006; Hopkins et al.,
2007; Rahmouni et al., 2008). Hypertension is a worldwide
health problem and the basic symptom of metabolic syn-
drome (Grundy et al., 2005). There are only a few studies in
the literature which have examined the risk factors for a rise
in arterial blood pressure caused by BMI, waist circumfer-
ence and other risk factors of metabolic syndrome in young
persons 18 to 25 years of age (Must et al., 1992; Lawlor et
al., 2006). This prompted us to study visceral obesity, hy-
pertension and glucose intolerance in young people, with
the goal of adding knowledge on means of prevention of
metabolic syndrome (Ekelund et al., 2009).
MATERIALS AND METHODS
Between 2007 and 2009, in the study we included 105 fe-
male students, aged 18–25, from the Red Cross Medical
College. We used 15 variables in data processing, and took
into account student permanent residence in one of the four
regions of Latvia. We calculated their BMI, abdominal cir-
cumference, lung vital capacity (ml), thyroid changes by ul-
trasound (USG) (27 students) and ECG (79 students). In ad-
dition, we measured their waist and chest circumferences,
and systolic and diastolic blood pressure in both arms. We
determined the concentration of glucose, adiponectin, thy-
roid stimulating hormone (TSH) and free thyroxine (FT4) in
blood. Statistical analysis of the data was performed using
the SPSS 15.01 package software. To determine significant
relationships we used the Pearson’s, Spearman’s Rho and
Kendall tau- b correlation coefficients.
RESULTS
The average systolic blood pressure (SBP) was normal
(113.54 ± 1.26 mmHg) with a tendency to increase with
BMI and waist circumference (Table 1).
SBP was higher in students with II degree of obesity
(134.67 ± 12.39 mmHg). SBP was related not only to BMI
(P = 0.002–0.0012), but also with waist circumference (P =
0.002–0.021) (Fig. 1.1 and 1.2). Diastolic blood pressure
(DBP) on average was normal (73.57 ± 1.1 mmHg) (see Ta-
ble 1).
In the group with II degree of obesity, DBP significantly
differed (93.67 ± 16.05 mmHg) in three students from the
others. A significant correlation was observed between DBP
and BMI level (P = 0.007), waist circumference (P = 0.009)
(Fig. 2.1 and 2.2) and hip circumference (P = 0.008) (Fig.
2.3). A significant correlation was also observed between
DBP and age at onset of menarche. DBP was higher (P =
0.009–0.017) when menarche began at a younger age (Fig.
2.4).
A significant relationship was observed between lung vital
capacity and the level of BMI (P = 0.013–0.032) (Fig. 3.1)
and waist circumference (P = 0.016–0.031) (Fig. 3.2).
ECG changes were found in 33% of cases (26 of 79 stu-
dents). 10% of cases had non-specific ST-segment and T-
wave changes. These ECG changes were associated with in-
creased waist circumference (P = 0.016–0.017) but not with
BMI (Fig. 4.1).
Glucose, adiponectin, TSH (thyroid stimulating hormone)
and free thyroxine (FT4) concentrations are shown in Table
2. Blood glucose levels were normal, with a mean value
4.57 ± 0.05 mmol/L (see Table 2). With increasing BMI
(P = 0.031) and waist circumference (P = 0.045), the con-
centration of blood glucose also increased (Fig. 5.1–5.2).
Adiponectin was determined in 38 students, and on average,
was within the normal range with a mean value 29.45 ±
1.29 mg/ml. There is significant increase in adiponectin
with increase of SBP and DBP. The correlation was
stronger with DBP (P = 0.002–0.003), but less with SBP
(P = 0.007–0.048) (see Fig. 6.1 and 6.2).
Ultrasonography detected thyroid nodules in three of the 27
students examined. These students were from the Kurzeme
and Vidzeme region (Table 1). The average TSH and free
thyroxine levels were within the normal range (Table 2).
With increase in thyroxine concentration, ECG ST-segment
changes were rarely observed (Fig. 7.1 and 7.2). Lung vital
capacity increased with a decrease of free thyroxine con-
centration (P = 0.0001) (Fig. 7.3).
DISCUSSION
The key feature of the metabolic syndrome is obesity,
which is evaluated by BMI, waist circumference (abdomi-
nal obesity) (Bruce et al., 2009; De Gonzalez et al., 2010).
Obesity contributes to insulin resistance in tissues, dyslipi-
demia, glucose intolerance, and to adipocitokin secretion,
and hypertension (Chiarelli et al., 2008; Steinberger et al.,
2009). Hypertension and glucose intolerance are major fac-
tors for cardiovascular diseases and diabetes mellitus, which
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have significant roles in the pathogenesis of the metabolic
syndrome (Després et al., 2008).
Systolic and diastolic blood pressure. In our study the av-
erage arterial pressure (SBP and DBP) was normal. A rise
in SBP and DBP was closely associated with increase in
BMI and waist circumference. SBP changes were mainly
related with BMI level and waist circumference, while
DBP was also related with other factors, such as hip circum-
ference. This indicates that gender and the endocrine system
may have an effect on the DBP changes in young women
(Veldhuis et al., 2005). Increase in BMI in school-age boys
was associated with a significant increase in DBP (Ligere et
al., 2001; 2002; Madrevica et al., 2002). As demonstrated
in our previous study, an increase in BMI and the waist cir-
cumference in school-age girls was observed together with
a rise in SBP (Ligere et al., 2001). This suggests that differ-
ent factors cause changes in DBP and that these factors
should be closely examined. In our study, DBP changed in
students who had their first menarche prematurely. An ear-
lier first menarche was associated with a higher DBP. There
are almost no research articles that describe this association
in the literature. It is mentioned in the literature that Spanish
girls with premature adrenarche and insulin resistance are
lean (Ibáñez et al., 2000). In our study, arterial pressure was
above normal in three students with the II degree of obesity
and 106.7 cm waist circumference. SBP, unlike DBP, does
not change depending on hip circumference and the age at
onset of menarche. This indicates a role of the endocrine
system and genetic factors in the overall pathogenesis of the
metabolic syndrome.
Vital capacity. As our studies show, vital capacity signifi-
cantly increases with increased BMI and waist circumfer-
ence. It should be mentioned that three students with the II
degree of obesity and increased waist circumference (106.7
T a b l e 1
MEASURES OF VARIABLES IN RELATION TO BMI (systolic and diastolic arterial tension, pulse, USG, ECG, vital capacity)
BMI degrees Statistical
descriptives


















Total Number of girls 105 105 105 105 105 27 79 105
Mean 22.7080 74.452 113.54 73.57 76.48 .33 3.61 2947.90
SEM .40696 1.0192 1.264 1.099 1.094 .092 .254 54.714
Minimum 17.51 59.0 90 50 50 0 0 1300
Maximum 39.55 114.0 157 114 115 1 5 4500
16.500–18.499 Number of girls 11 11 11 11 11 3 10 11
Mean 17.9291 66.500 105.64 71.27 72.91 .67 3.50 2972.73
SEM .10299 1.3568 4.110 3.287 3.386 .333 .764 208.933
Minimum 17.51 62.0 92 50 55 0 0 1800
Maximum 18.44 77.0 139 85 98 1 5 4500
18.500–24.999 Number of girls 70 70 70 70 70 12 52 70
Mean 21.3390 70.957 113.44 72.64 76.91 .25 3.65 2839.00
SEM .19033 .7373 1.373 1.253 1.353 .131 .311 60.503
Minimum 18.83 59.0 90 50 50 0 0 1300
Maximum 24.82 85.0 157 99 115 1 5 4500
25.000–29.999 Number of girls 18 18 18 18 18 9 11 18
Mean 27.1967 84.111 114.72 75.06 75.61 .33 3.64 3250.00
SEM .37755 1.5401 2.432 1.921 2.715 .167 .704 148.467
Minimum 24.97 74.0 100 60 53 0 0 2200
Maximum 29.94 98.0 135 85 94 1 5 4200
30.000–34.999 Number of girls 3 3 3 3 3 1 3 3
Mean 30.4867 96.000 116.67 74.67 79.00 1.00 3.33 3400.00
SEM .10682 4.5826 16.707 7.860 3.512 * 1.667 100.000
Minimum 30.30 90.0 98 64 72 1 0 3200
Maximum 30.67 105.0 150 90 83 1 5 3500
35.000–39.999 Number of girls 3 3 3 3 3 2 3 3
Mean 37.4633 105.667 134.67 93.67 82.00 .00 3.33 3133.33
SEM 1.22142 4.4096 12.387 16.045 7.638 .000 1.667 185.592
Minimum 35.32 99.0 110 62 72 0 0 2900
Maximum 39.55 114.0 149 114 97 0 5 3500
SEM, Standard Error of the Mean
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Systolic arterial tension
Fig. 1. Relationship between systolic arterial tension in the right arm (mmHg) and BMI (1) and waist circumference (2).
1 2





cm) had lower vital capacity than three students with the I
degree of obesity and increased waist circumference (96
cm). The first three students might be at risk for future
breathing and cardiovascular problems.
Glucose tolerance disorders. Glucose intolerance is one of
the major components of metabolic syndrome, which is as-
sociated with insulin resistance, diabetes mellitus and car-
diovascular diseases (Kaplan et al., 1989; De Fronzo et al.,
1991). Large-scale studies have show that glucose meta-
bolic disorders, regardless of metabolic syndrome, increase
carcinogenic risk in women more than in men (Stocks et al.,
2009). In our study, glucose concentration in blood was
within the normal range and was correlated with BMI and
waist circumference. Thus, the study shows that young
women 18 to 25 years of age with overweight and I and II
degree of obesity fit in the large scheme of symptoms of
metabolic syndrome and that they may be in a risk group for
serious health problems in the future.
ECG changes. Significant ECG changes (ST segment)
were found in 8 of 79 students. Increased waist circumfer-
ence was associated with ECG changes. This indicates that
visceral obesity is closely correlates with cardiovascular
changes in young women. Visceral obesity and insulin re-
sistance are the main risk factors for metabolic syndrome
(Grundy et al., 2005). Localisation of ectopic fat promotes
secretion of adipokines (also adiponectin) causing chronic
inflammation and endothelial dysfunction (Steinberger et
al., 2009; Potenza et al., 2009) and facilitates the manifesta-
tion of cardiovascular diseases.
Adiponectin. Adiponectin concentration correlated with ar-
terial pressure and pulse frequency, which can be explained
by a compensatory mechanism of the cardiovascular sys-
tem. The increase in adiponectin concentration could be re-
lated to the subject age (Kizer et al., 2011; Nishimura et al.,
2009). There are studies in the literature showing that adi-
ponectin has an additional role in the normalisation of blood
pressure in young people (Lambert et al., 2009). Cardiopro-
tective properties and reduction of risk to develop type 2
diabetes mellitus by adiponectin are being extensively stud-
ied at present (Li et al., 2009; Hopkins et al., 2007; Wang et
al., 2008), and the mechanisms have been explained by the
effect of adiponectin on size of lipoprotein particles, regard-
less of the degree of obesity or insulin resistance (Weiss et
al., 2009).
More and more studies are now appearing in the literature
on the role of genetic factors in the pathogenesis of meta-
bolic syndrome (Grundy, 2005; Terán-Garcia et al., 2007;
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Vital capacity (ml)
Fig. 3. Relationship between vital capacity (ml) and BMI degrees (1) and waist circumference (2).
1 2
ECG (electrocardiography) changes
Fig. 4. Relationship between change in ECG (electrocardiography) and
waist circumference (1) and ST wave changes.
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T a b l e 2
MEASURES OF VARIABLES IN RELATION TO BMI (sugar in blood, TSH, thyroxine, adiponectin)
BMI degrees Statistical
descriptives








Total N 105 105 105 105 105 38
Mean 22.7080 74.452 4.567 1.552 15.778 22.445
SEM 0.40696 1.0192 0.0482 0.0746 0.1669 1.2850
Minimum 17.51 59.0 3.0 0.5 11.4 8.5
Maximum 39.55 114.0 6.6 3.7 20.8 33.3
16.500–18.499 N 11 11 11 11 11 5
Mean 17.9291 66.500 4.464 1.375 16.673 18.100
SEM 0.10299 1.3568 0.1064 0.1997 0.6065 3.4486
Minimum 17.51 62.0 3.7 0.7 14.1 9.8
Maximum 18.44 77.0 4.8 3.0 20.1 29.7
18.500–24.999 N 70 70 70 70 70 26
Mean 21.3390 70.957 4.524 1.594 15.720 23.738
SEM 0.19033 0.7373 0.0567 0.0948 0.1988 1.5475
Minimum 18.83 59.0 3.0 0.5 11.4 8.5
Maximum 24.82 85.0 6.6 3.7 20.8 33.3
25.000–29.999 N 18 18 18 18 18 5
Mean 27.1967 84.111 4.667 1.382 15.300 20.100
SEM 0.37755 1.5401 0.1469 0.1558 0.3764 2.4700
Minimum 24.97 74.0 3.5 0.5 11.4 14.4
Maximum 29.94 98.0 5.9 3.2 17.2 26.3
30.000–34.999 N 3 3 3 3 3
Mean 30.4867 96.000 5.033 1.933 15.133
SEM 0.10682 4.5826 0.2848 0.5487 0.2963
Minimum 30.30 90.0 4.7 1.0 14.7
Maximum 30.67 105.0 5.6 2.9 15.7
35.000–39.999 N 3 3 3 3 3 2
Mean 37.4633 105.667 4.867 1.867 17.367 22.350
SEM 1.22142 4.4096 0.1856 0.5783 1.0868 10.9500
Minimum 35.32 99.0 4.5 1.1 15.2 11.4
Maximum 39.55 114.0 5.1 3.0 18.6 33.3
SEM, Standard Error of the Mean
Glucose in the blood
Fig. 5. Relationship between glucose in the blood and BMI (1) and waist circumference (2).
1 2
Garaulet et al., 2009; Steingerger et al., 2009; Bruce et al.,
2009).
Thyroid hormones. Thyroid hormones — free thyroxine
(FT4), thyroid-stimulating hormone (TSH) and free triiodo-
thyronine (FT3) cause weight changes. Weight gain has
been linked with subclinical thyroid disease, which is re-
lated both to insulin resistance (Brenta 2011) and increases
in TSH and T3 (triiodothyronine) concentrations (Reinehr,
2012).
The rise in TSH levels in students with I and II degree of
obesity indicates the role of thyroid hormones in regulation
of metabolism. In our study, thyroxine and TSH concentra-




Fig. 6. Relationship between adiponectin concentration and systolic (1) and diastolic (2) arterial tension in the right arm.
Correlation of ECG
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Fig. 7. Relationship of ECG changes and free thyroxine (FT4) and thy-
roid-stimulating hormone (TSH) concentrations (Fig. 7.1 and 7.2). Relation-
ship between vital capacity and FT4 (Fig. 7.3)
1 2
3
Our study clearly showed correlation between arterial blood
pressure and both BMI and waist circumference in students.
The rise in DBP in students was also associated with in-
crease of the hip circumference and age of onset of men-
arche. The blood glucose concentration was also closely as-
sociated with BMI and waist circumference. In contrast, an
increase in adiponectin in women aged 18 to 25 years was
associated with cardiovascular indicators (DBP and SBP,
pulse frequency), but was not associated with an increase in
BMI and waist circumference. Changes in thyroid function
were related to the ECG ST-segment abnormalities. Thus,
the main risk factors of metabolic syndrome and their rela-
tionships can already be observed in young women aged 18
to 25 years.
Increase of systolic and diastolic blood pressure, as well as
increase in blood glucose concentration are closely associ-
ated with both BMI and waist circumference. These find-
ings shoud be kept in mind when considering the impor-
tance of both factors in the pathogenesis of metabolic
syndrome and arterial hypertension in young women.
Changes in adiponectin and ECG are linked to an increase
in waist circumference, and changes in thyroxin and TSH
levels. An increase in diastolic blood pressure is related to
student age at onset of menarche, indicating a possible role
for genetic factors and the endocrine system in the patho-
genesis of the matabolic syndrome.
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METABOLÂ SINDROMA RISKA FAKTORU IZVÇRTÇJUMS STUDENTÇM
Studentçm, kuru vidçjais vecums ir 20,7 gadi, skaidri iezîmçjas pozitîva sakarîba starp arteriâlâ spiediena, íermeòa masas indeksa (ÍMI) un
vidukïa apkârtmçra palielinâðanos. Vidçjais sistoliskais (SAS) un diastoliskais asinsspiediens (DAS) studentçm ir optimâls (SAS 113,54 ±
1,26; DAS 73,57 ± 1,09). SAS cieði korelç ar ÍMI pakâpçm (P = 0,02–0,012) un vidukïa apkârtmçru (P = 0,002–0,02). DAS cieði korelç ne
tikai ar ÍMI (P = 0,007) un vidukïa apkârtmçru (P = 0,009), bet arî ar gûþu apkârtmçra palielinâðanos (P = 0,008). Bûtiska ietekme uz DAS
palielinâðanos ir vecumam, kad iestâjas menarche (P = 0,009–0,017). DAS ir augstâk studentçm, kuras ir jaunâkas menarche iestâðanâs
laikâ. Sakarîba varçtu norâdît par ìençtisko faktoru un endokrînâs sistçmas lomu DAS regulâcijâ. Plauðu vitâlâ kapacitâte studentçm
palielinâs cieðâ saistîbâ ar ÍMI (P = 0,013–0,032) un vidukïa apkârtmçra (P = 0,016–0,032) palielinâðanos. Glikozes koncentrâcijas
palielinâðanâs asinîs ir cieði saistîta ar ÍMI (P = 0,03) un vidukïa apkârtmçra (P = 0,0045) palielinâðanos. Turpretî adiponektîna
koncentrâcijas izmaiòas ir saistîtas ar sistoliskâ (P = 0,007–0,048) un diastoliskâ (P = 0,002–0,003) arteriâlâ spiediena palielinâðanos, kas
liecina par abu râdîtâju atðíirîgiem regulâcijas mehânismiem. EKG izmaiòas novçrojamas 33% (26 studentçm no 79) gadîjumu, bet EKG
ST segmenta izmaiòas novçrojamas 10% gadîjumu, kas liecina par nopietnâm sirds asinsvadu izmaiòâm jaunâm sievietçm, kuras korelç ar
vidukïa apkârtmçra palielinâðanos (P = 0,016-0,017).
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